A case of methotrexate-associated lymphoproliferative disorders in the oral floor

DOI Web Site 6 Citations 39 References
  • SHIBAYAMA Naohiro
    Department of Oral and Maxillofacial Surgery, Asahikawa Medical University
  • KONDO Eiji
    Department of Oral and Maxillofacial Surgery, Asahikawa Medical University
  • YOSHIDA Masatsugu
    Department of Oral and Maxillofacial Surgery, Asahikawa Medical University
  • TAKEKAWA Masanori
    Department of Oral and Maxillofacial Surgery, Asahikawa Medical University
  • MATSUDA Mitsuyoshi
    Department of Oral and Maxillofacial Surgery, Asahikawa Medical University
  • MIYOKAWA Naoyuki
    Department of Pathology, Asahikawa Medical University Hospital

Bibliographic Information

Other Title
  • 口底にメトトレキサート関連性リンパ増殖性疾患を発症した1例
  • クチテイ ニ メトトレキサート カンレンセイ リンパ ゾウショクセイ シッカン オ ハッショウ シタ 1レイ

Search this article

Description

Methotrexate （MTX） is administered to patients with rheumatoid arthritis （RA） as standard treatment. Tumor necrosis factor （TNF） antagonist, which was recently approved for use in Japan, also shows excellent clinical effectiveness. However, these agents may increase the risk of malignant lymphoma. We report a case of methotrexate-associated lymphoproliferative disorder （MTX-LPD） after chemotherapy with MTX and TNF antagonists. <br>A 52-year-old woman presented because of pain in the left oral floor with an ulcer in June 2009. The patient had received MTX therapy for RA for 3 years since 2006, as well as TNF antagonists for 2 years from 2007. The diagnosis of‘ diffuse large B-cell lymphoma’ was established by biopsy of the focus. MTX therapy was discontinued on consultation with her doctor, and the ulcer disappeared in 4 months without any further chemotherapy for lymphoma.

Journal

Citations (6)*help

See more

References(39)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top